Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,529 | 288 | 98.0% |
| Education | $70.80 | 12 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $521.00 | 59 | $0 (2020) |
| Novo Nordisk Inc | $463.00 | 41 | $0 (2024) |
| Amgen Inc. | $361.29 | 20 | $0 (2020) |
| GlaxoSmithKline, LLC. | $308.83 | 36 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $274.40 | 12 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $188.31 | 17 | $0 (2019) |
| Amarin Pharma Inc. | $174.22 | 17 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $163.76 | 13 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $130.21 | 9 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $127.70 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.14 | 1 | Novo Nordisk Inc ($15.14) |
| 2023 | $17.94 | 1 | Novo Nordisk Inc ($17.94) |
| 2022 | $18.22 | 1 | ABBVIE INC. ($18.22) |
| 2020 | $245.08 | 15 | Amgen Inc. ($54.13) |
| 2019 | $1,223 | 97 | Novo Nordisk Inc ($221.44) |
| 2018 | $1,132 | 87 | PFIZER INC. ($181.50) |
| 2017 | $948.55 | 98 | GlaxoSmithKline, LLC. ($157.88) |
All Payment Transactions
300 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Diabetes | ||||||
| 11/17/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Diabetes | ||||||
| 11/03/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Neuroscience | ||||||
| 03/09/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.41 | General |
| Category: Cardiovascular | ||||||
| 02/27/2020 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: ADHD | ||||||
| 02/20/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Neuroscience | ||||||
| 02/19/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Diabetes | ||||||
| 02/13/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/11/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiovascular | ||||||
| 02/03/2020 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $23.08 | General |
| Category: AED | ||||||
| 01/23/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.82 | General |
| 01/17/2020 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Respiratory and Allergy | ||||||
| 01/16/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Central Nervous System | ||||||
| 01/13/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Neuroscience | ||||||
| 01/10/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/06/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/03/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Cardiovascular | ||||||
| 12/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/13/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/13/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Diabetes | ||||||
| 12/13/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $5.90 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/11/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: GASTROINTESTINAL | ||||||
| 12/11/2019 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $1.98 | General |
| Category: GASTROINTESTINAL | ||||||
| 11/22/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.81 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 187 | 254 | $43,206 | $13,400 |
| 2022 | 3 | 253 | 390 | $63,826 | $19,800 |
| 2021 | 2 | 244 | 365 | $56,315 | $19,806 |
| 2020 | 2 | 214 | 296 | $41,576 | $12,171 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 180 | $33,660 | $10,356 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 74 | $9,546 | $3,044 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 256 | $47,872 | $15,067 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 122 | $15,738 | $4,676 | 29.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 11 | 12 | $216.00 | $57.44 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 166 | 249 | $42,738 | $14,548 | 34.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 116 | $13,577 | $5,257 | 38.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 129 | 179 | $28,998 | $8,364 | 28.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 85 | 117 | $12,578 | $3,807 | 30.3% |
About Dr. Scott Addison, MD
Dr. Scott Addison, MD is a Family Medicine healthcare provider based in Norton Shores, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548236888.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Addison, MD has received a total of $3,599 in payments from pharmaceutical and medical device companies, with $15.14 received in 2024. These payments were reported across 300 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,529).
As a Medicare-enrolled provider, Addison has provided services to 898 Medicare beneficiaries, totaling 1,305 services with total Medicare billing of $65,177. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Norton Shores, MI
- Active Since 02/27/2006
- Last Updated 01/11/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1548236888
Products in Payments
- CHANTIX (Drug) $291.69
- Tresiba (Drug) $175.36
- Vascepa (Drug) $174.22
- Aimovig (Biological) $134.60
- ELIQUIS (Drug) $132.95
- SYMBICORT (Drug) $128.16
- ENTRESTO (Drug) $115.03
- Prolia (Biological) $107.74
- FARXIGA (Drug) $107.67
- XARELTO (Drug) $99.44
- SEEBRI (Drug) $96.67
- Repatha (Biological) $81.77
- JARDIANCE (Drug) $80.69
- VIAGRA (Drug) $76.64
- Ozempic (Drug) $76.23
- ANORO (Drug) $71.59
- PRADAXA (Drug) $71.23
- ADVAIR (Drug) $70.09
- INVOKANA (Drug) $64.32
- LYRICA (Drug) $60.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Norton Shores
Dr. James Twesten-Otoole, Md, MD
Family Medicine — Payments: $2,668
Gabriel Dunn, M.d, M.D
Family Medicine — Payments: $2,557
Michael Banka, Md, MD
Family Medicine — Payments: $1,705
Dr. David Booth, Md, MD
Family Medicine — Payments: $1,684
Dr. Todd Rexford, Md, MD
Family Medicine — Payments: $1,674
Alex Wagner, Do, DO
Family Medicine — Payments: $1,549